CDEK
← All organizations

Telix

For profitWebsite ↗

Also known as: TELIX | TELIX INNOVATIONS | Telix International Pty Ltd | Telix Pharmaceutical | Telix Pharmaceuticals (Innovations) Pty Limited | Telix Pharmaceuticals (Innovations) Pty Ltd | Telix Pharmaceuticals, Ltd

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

May 10, 2019

First marketed drug

Dec 17, 2021

Last known activity

Nov 2, 2025

Timeline

2010s

  1. Jan 1, 2017

    Telix— Founded

  2. Nov 26, 2018

    Advanced Nuclear Medicine Ingredients— Acquired

2020s

  1. Dec 17, 2021

    Ga 68 PSMA-11— Marketing Organization

  2. Dec 17, 2021

    Ga 68 PSMA-11— NDA Secondary Org

  3. Nov 14, 2023

    QSAM Therapeutics, Inc.— Acquired

Drugs by trial phase (16 distinct, 25 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (24)

Details

Founded
Melbourne, AU Jan 1, 2017
Last known activity
Nov 2, 2025